President and CEO of Chemocentryx Inc (CCXI) Thomas J. Schall sells 7,500 shares of CCXI on 02/22/2013 at an average price of $12.06 a share.

Chemocentryx Inc has a market cap of $453.5 million; its shares were traded at around $12.4 with and P/S ratio of 11.7.

CEO Recent Trades:

• President and CEO Thomas J. Schall sold 7,500 shares of CCXI stock on 02/22/2013 at the average price of 12.06. Thomas J. Schall owns at least 2,231,167 shares after this. The price of the stock has increased by 2.82% since.
• President and CEO Thomas J. Schall sold 2,100 shares of CCXI stock on 11/20/2012 at the average price of 12.01. Thomas J. Schall owns at least 2,238,667 shares after this. The price of the stock has increased by 3.25% since.
• President and CEO Thomas J. Schall sold 20,400 shares of CCXI stock on 11/16/2012 at the average price of 12.58. Thomas J. Schall owns at least 2,240,767 shares after this. The price of the stock has decreased by 1.43% since.
• President and CEO Thomas J. Schall sold 22,500 shares of CCXI stock on 11/06/2012 at the average price of 12.01. Thomas J. Schall owns at least 2,279,167 shares after this. The price of the stock has increased by 3.25% since.
• President and CEO Thomas J. Schall sold 15,000 shares of CCXI stock on 10/01/2012 at the average price of 11.53. Thomas J. Schall owns at least 2,301,667 shares after this. The price of the stock has increased by 7.55% since.

CFO Recent Trades:

• SVP, Finance, CFO and Sec. Susan M Kanaya sold 666 shares of CCXI stock on 02/22/2013 at the average price of 11.91. The price of the stock has increased by 4.11% since.
• SVP, Finance, CFO and Sec. Susan M Kanaya sold 19,334 shares of CCXI stock on 02/21/2013 at the average price of 11.91. The price of the stock has increased by 4.11% since.
• SVP, Finance, CFO and Sec. Susan M Kanaya sold 5,927 shares of CCXI stock on 12/04/2012 at the average price of 11.97. The price of the stock has increased by 3.59% since.
• SVP, Finance, CFO and Sec. Susan M Kanaya sold 4,073 shares of CCXI stock on 11/29/2012 at the average price of 11.89. The price of the stock has increased by 4.29% since.
• SVP, Finance, CFO and Sec. Susan M Kanaya sold 16,029 shares of CCXI stock on 11/06/2012 at the average price of 11.91. The price of the stock has increased by 4.11% since.

Directors and Officers Recent Trades:

• 10% Owner Partners L P/il Bvf bought 40,000 shares of CCXI stock on 11/06/2012 at the average price of 12. Partners L P/il Bvf owns at least 3,750,277 shares after this. The price of the stock has increased by 3.33% since.
• 10% Owner Partners L P/il Bvf bought 40,000 shares of CCXI stock on 11/06/2012 at the average price of 12. Partners L P/il Bvf owns at least 376,150 shares after this. The price of the stock has increased by 3.33% since.
• SVP of Medical & Clinical Petrus Bekker sold 15,000 shares of CCXI stock on 02/22/2013 at the average price of 12.07. Petrus Bekker owns at least 53,594 shares after this. The price of the stock has increased by 2.73% since.
• SVP, Drug Discovery & CSO Juan C. Jaen sold 22,201 shares of CCXI stock on 02/21/2013 at the average price of 11.9. Juan C. Jaen owns at least 45,000 shares after this. The price of the stock has increased by 4.2% since.
• SVP, Drug Discovery & CSO Juan C. Jaen sold 1,945 shares of CCXI stock on 02/15/2013 at the average price of 11.74. Juan C. Jaen owns at least 53,000 shares after this. The price of the stock has increased by 5.62% since.

For the complete insider trading history of CCXI, click here.